Shareholders Equity and Capital Stock (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2023
$ / shares
shares
| |
| Shareholders Equity and Capital Stock | |
| Outstanding, Beginning Balance | shares | 8,574,904 |
| Granted, Options | shares | 1,371,432 |
| Exercised, options | shares | (536,183) |
| Outstanding Ending Balance, Options | shares | 9,410,153 |
| Outstanding, Beginning Balance, Weighted-average exercise price | $ / shares | $ 0.66 |
| Granted, Weighted-average exercise price | $ / shares | 1.15 |
| Exercised, Weighted-average exercise price | $ / shares | 0.55 |
| Outstanding Ending Balance, Weighted-average exercise price | $ / shares | $ 0.74 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|